Skip to main content
SpringerLink
Log in

Management of the Neck in Oral Cavity Cancer

  • Chapter
  • First Online:
Contemporary Oral Oncology

Abstract

Oral cancer is unusual in the Western countries, with an estimated 27,450 new cases for 2013 in the USA [1]. There has been a significant increase in 5-year relative survival rate between 1975–1978 and 2002–2008 of 53 % vs 65 % for all races, 54 % vs 67 % for whites, and 36 % vs 45 % for blacks. All of these were statistically significant (p < .05), although survival is still worse in blacks than whites [1]. This data is not true on global scale, and in many countries such as the Indian subcontinent, oral cavity cancer is more commonly seen due to habits such as the chewing of Betel Nut.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2013. CA Cancer J Clin. 2013;63:11–30.

    PubMed  Google Scholar 

  2. Shah JP, Candela FC, Poddar AK. The patterns of cervical metastases from squamous cell carcinoma of the oral cavity. Cancer. 1990;66:109–11.

    CAS  PubMed  Google Scholar 

  3. Shah JP, Andersen PE. The impact of nodal metastasis on modifications of neck dissection. Ann Surg Oncol. 1994;1(6):521–32.

    CAS  PubMed  Google Scholar 

  4. Li XM, Wei WI, Guo XF, Yeun PW, Lam LK. Cervical lymph node metastatic patterns of squamous cell carcinomas in the upper aerodigestive tract. J Laryngol Otol. 1996;110(10):937–41.

    CAS  PubMed  Google Scholar 

  5. Spiro JD, Spiro RH, Shah JP, Sessions RB, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg. 1988;156(4):286–9.

    CAS  PubMed  Google Scholar 

  6. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York/Dordrecht/Heidleberg/London: Springer; 2010.

    Google Scholar 

  7. Shah JP, Tollefson HR. Epidermoid carcinoma of the supraglottic larynx, role of neck dissection in initial surgical treatment. Am J Surg. 1974;128:494–9.

    CAS  PubMed  Google Scholar 

  8. Ord RA. Current concepts in managing the neck in squamous cell carcinoma of the oral cavity. Oral Maxillofac Clin N Am. 1997;9(23):385–96.

    Google Scholar 

  9. Lyddiatt DD, Markin RS, Williams SM, Davis LF, Yonkers AJ. Computed tomography and magnetic resonance of cervical metastases of squamous cell carcinoma HeusschPHEof the upper respiratory and digestive tract. Otolaryngol Head Neck Surg. 1989;101:422–5.

    Google Scholar 

  10. Stern WB, Silver CE, Zeifer BA, Persky MS, Heller KS. Computed tomography of the clinically negative neck. Head Neck. 1990;12(2):109–13.

    CAS  PubMed  Google Scholar 

  11. Som PM. Lymph nodes of the head and neck. Radiology. 1987;165(3):593–600.

    CAS  PubMed  Google Scholar 

  12. Erkan MR, Ol AT, Guney E. Ultrasonography in laryngeal cancers. J Laryngol Otol. 1993;17:293–7.

    Google Scholar 

  13. Menda Y, Graham MM. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med. 2005;35(4):214–9.

    PubMed  Google Scholar 

  14. Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47(5):755–62.

    PubMed  Google Scholar 

  15. Ozer E, Naiboğlu B, Meacham R, Ryoo C, Ryoo C, Argawal A, Schuller DE. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol. 2012;269(11):2411–4.

    PubMed  Google Scholar 

  16. Varoquax A, Rager O, Poncet A, Delattre BM, Rahib O, Becker CD, Dulqueroy N, Zaidi H, Becker M. Detection and quantification of focal uptake in head and neck tumors: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2014;41(3):462–75.

    Google Scholar 

  17. Norling R, Burton BM, Thirkildsen MH, Henricksen BM, von Buchwald C, Nielsen MB. Staging of cervical lymph nodes in oral squamous cell carcinoma: adding ultrasound in clinically lymph node negative neck may improve diagnostic work-up. PLoS One. 2014;20(3):e90360.

    Google Scholar 

  18. Heusch P, Sproll C, Buchbender C, Rieser E, Teriung J, Antke C, Boeck I, Macht S, Scherer A, Antoch G, Heusner TA, Handschel J. Diagnostic accuracy of ultrasound, 18F-FDG –PET Ct and fused 18 F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC. Clin Oral Investig. 2014;18(3):969–78.

    PubMed  Google Scholar 

  19. Chaukar D, Dandekar M, Kane S, Arya S, Purandare N, Rangaraian V, Desmukh A, Pal P, Chaturvedi P, D’Cruz A. Relative value of ultrasound, computed tomography imaging in the clinically node-negative neck in oral cancer. Asia Pac J Clin Oncol. 2014. doi:10.1111/ajco.12255 (Epub ahead of print).

    Article  PubMed  Google Scholar 

  20. Liao LJ, Lo WC, Hsu WI, Wang CT, Lai MS. Detection of cervical node metastasis in head and neck cancer patients with clinically N0 neck- a meta-analysis comparing different imaging modalities. BMC Cancer. 2012;12:236.

    PubMed  PubMed Central  Google Scholar 

  21. Norling R, Grau C, Nielsen MB, Homøe P, Sørenson JA, Lambersen K, Bundgaard T, Mäkitie A, Grénman R, Larenne J, Koivunen P, Virtaniemi J, Gudionsson A, Jeflund O, Abendstein H, Rikardsen O, Lybak S, Wennerberg J, Högmo A, Westborn A, Hammerlid E, Tylor W, Cederblad L, von Buchwald C. Radiological imaging of the neck for initial decision making in oral squamous cell carcinomas- a questionnaire survey in the Nordic countries. Acta Oncol. 2012;51(3):355–61.

    PubMed  Google Scholar 

  22. Furukawa M, Dillon JK, Futran ND, Anzai Y. The prevelance of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging? Acta Radiol. 2014;55(5):570–8.

    PubMed  Google Scholar 

  23. Joo Y, Yoo IR, Cho KJ, Park JO, Nam IC, Kim MS. Extracapsular spread and FDG PET/CT correlation in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2013;42(2):158–63.

    CAS  PubMed  Google Scholar 

  24. Joo YH, Yoo LR, Cho KJ, Park JO, Nam IC, Kim MS. Standardized uptake value and resection value and resection margin involvement predict outcomes in pN0 head and neck cancer. Otolaryngol Head Neck Surg. 2013;149(5):721–6.

    PubMed  Google Scholar 

  25. Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM. Analysis of pre-treatment FDG-PET SUV parameters in head and neck cancer. SUV mean has superior diagnostic value. Int J Radiat Oncol Biol Phys. 2012;82(2):548–53.

    PubMed  Google Scholar 

  26. Choi KH, Yoo LR, Han EJ, Kim YS, Kim GW, Na SJ, Di S, Jung SL, Jung CK, Kim MS, Lee SY, Kim SH. Prognostic value of metabolic tumor volume measured by (18)F-FDG PET/CT in locally advanced head and neck squamous cell carcinomas treated by surgery. Nucl Med Mol Imaging. 2011;45(1):43–51.

    PubMed  Google Scholar 

  27. Deron P, Mertens K, Goethals I, Rottey S, Duprez F, De Neve W, Vermeersch H, Van de Wiele C. Metabolic tumor prognostic value in locally advanced squamous cell carcinoma of the head and neck. Nuklearmedizin. 2011;50(4):141–6.

    CAS  PubMed  Google Scholar 

  28. Lee JC, Kim JS, Lee JH, Nam SY, Choi SH, Lee SW, Kim SB, Kim SY. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol. 2007;43(7):686–92.

    CAS  PubMed  Google Scholar 

  29. Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Choi KJ, Lee SW, Kim SB, Roh JL. Evaluation of 18F- FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Ann Surg Oncol. 2011;18(9):2579–84.

    PubMed  Google Scholar 

  30. Baatenberg de Jong RJ, Rohgen RJ, Verwoerd CD, van Overhagen H, Laméris JS, Knegt P. Ultrasound-guided fine needle aspiration biopsy of neck nodes. Arch Otolaryngol Head Neck Surg. 1991;117:402–4.

    Google Scholar 

  31. Van de Brekel MW, Catelijns JA, Siel HV, Luth WJ, Valk J, van der Waal I, Snow GB. Occult metastatic neck disease detection with US and US-guided fine needle aspiration cytology. Radiology. 1991;180:457–61.

    PubMed  Google Scholar 

  32. Stoeckli SJ, Haerle SK, Strobel K, Haile SR, Hany TF, Schuknecht B. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck. 2012;34(4):469–76.

    PubMed  Google Scholar 

  33. Flezar MS, Kirbis IS, Popović KS, Strojan P. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study. Radiother Oncol. 2009;93(3):575–80.

    PubMed  Google Scholar 

  34. Adoga AA, Silas OA, Nimkur TL. Open cervical lymph node biopsy for head and neck cancers: any benefit? Head Neck Oncol. 2009;1:9.

    PubMed  PubMed Central  Google Scholar 

  35. Parsons JT, Million RR, Cassisi NJ. The influence of excisional or incisional biopsy of metastatic neck nodes on the management of head and neck cancer. Int J Radiat Oncol Biol Phys. 1985;11:1447–54.

    CAS  PubMed  Google Scholar 

  36. Vandenbrouk C, Sancho-garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer. 1980;46(2):386–90.

    Google Scholar 

  37. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989;153(4):309–13.

    Google Scholar 

  38. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994;168(5):391–4.

    CAS  PubMed  Google Scholar 

  39. Yeun APW, Ho CM, Chow TL, Tang LC, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31(6):765–72.

    Google Scholar 

  40. Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope. 2000;110(12):2037–40.

    CAS  PubMed  Google Scholar 

  41. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg. 1996;114(1):65–70.

    CAS  PubMed  Google Scholar 

  42. Anderson PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the neck. Am J Surg. 1996;172(6):689–91.

    Google Scholar 

  43. Yeun APW, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the surgical treatment of early oral tongue carcinoma. Head Neck. 1997;19:583–8.

    Google Scholar 

  44. Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112(11):1970–4.

    PubMed  Google Scholar 

  45. Nieuwenhuis EJ, Leemans CR, Kimmer JA, Denkers F, Snow GB, Brakenhokk RH. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription- polymerase chain reaction. Lab Invest. 2003;83(8):1233–40.

    CAS  PubMed  Google Scholar 

  46. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong E. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg. 1986;152:345–50.

    CAS  PubMed  Google Scholar 

  47. Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashburg A. Relation of thickness of floor of mouth stage I and II cancers to metastasis. Am J Surg. 1986;152(4):351–3.

    CAS  PubMed  Google Scholar 

  48. Weiss MH, Harrison LB, Isaacs R. Use of decision analysis in planning a management strategy for the stage No neck. Arch Otolaryngol Head Neck Surg. 1994;120:694–702.

    Google Scholar 

  49. Kraus DH, Rosenberg DB, Davidson BJ, Shaha AR, Spiro RH, Strong EW, Schantz SP, Shah JP. Supraspinal accessory nerve lymph node metastases in supraomohyoid neck dissection. Am J Surg. 1996;172(6):646–9.

    CAS  PubMed  Google Scholar 

  50. Talmi YP, Hoffman HT, Horowitz Z, McCullough TM, Funk GF, Graham SM, Peleg M, Yahalom R, Teicher S, Kroneberg J. Patterns of metastases to the upper jugular lymph nodes (the “submuscular recess”). Head Neck. 1998;20(8):682–6.

    CAS  PubMed  Google Scholar 

  51. Byers RM, Weber RS, Andrews T, Mc Gill D, Kare R, Wolf P. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997;19(1):14–9.

    CAS  PubMed  Google Scholar 

  52. Khafif A, Lopez-Garza JR, Medina JE. Is dissection of level IV necessary in patients with T1-3 N0 tongue cancer? Laryngoscope. 2001;111(6):1088–90.

    CAS  PubMed  Google Scholar 

  53. Leemans CR, Tiwari R, Naula JJ, Snow GB. Discontinuity vs in-continuity neck dissection in carcinoma of the oral cavity. Arch Otolaryngol Head Neck Surg. 1991;117(9):1003–6.

    CAS  PubMed  Google Scholar 

  54. Tesseroli MA, Calabrese L, Carvalho AL, Kowalski LP, Chiesa F. Discontinuous vs in-continuity dissection in carcinoma of the oral cavity. Experience of two oncologic hospitals. Arch Otolaryngol. 2006;26(6):350–5.

    CAS  Google Scholar 

  55. Zhang T, Ord RA, Wei WI, Zhao J. Sublingual lymph node metastases of early tongue cancer: report of two cases and review of the literature. Int J Oral Maxillofac Surg. 2011;40(6):597–600.

    CAS  PubMed  Google Scholar 

  56. Million RR. Is survival affected by elective irradiation of clinically uninvolved (N0) neck lymph nodes. [letter]. Int J Radiat Oncol Biol Phys. 1986;12:437–9.

    Google Scholar 

  57. August M, Gianette K. Elective neck irradiation versus observation of the clinically negative neck of patients with oral cancer. J Oral Maxillofac Surg. 1996;54:1050–5.

    CAS  PubMed  Google Scholar 

  58. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972;29:1450–4.

    CAS  PubMed  Google Scholar 

  59. Medina JE, Byers RM. Supra-omohyoid neck dissection: rationale, indications and surgical technique. Head Neck. 1989;11:111–22.

    CAS  PubMed  Google Scholar 

  60. Ord RA, Cornella FA. Modified radical and selective neck dissections. Atlas Oral Maxillofac Surg Clin North Am. 1997;5(2):111–32.

    CAS  PubMed  Google Scholar 

  61. http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp.

  62. Cooper JS, Palak TS, Forasttiere AA, et al.; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937–44.

    Google Scholar 

  63. Bernier J, Domenge C, Ozsahin M, et al.; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945–52.

    Google Scholar 

  64. Bernier J, Pfister DG, Cooper JS. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinoma. Crit Rev Oncol Hematol. 2005;56(3):353–64.

    PubMed  Google Scholar 

  65. Bernier J, Cooper JS, Palak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27(10):843–50.

    PubMed  Google Scholar 

  66. Bernier J, Vermorken JB, Koch WM. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol. 2006;24(17):2629–35.

    PubMed  Google Scholar 

  67. Crile G. Excision of cancer of the head and neck with special reference to the plan of dissection based upon one hundred and thirty-two operations. JAMA. 1906;47:1780–6.

    Google Scholar 

  68. Lingeman RE, Helmus C, Stephens R, Ulm J. Neck dissection: radical or conservative. Ann Otol Rhinol Laryngol. 1977;86:737–44.

    CAS  PubMed  Google Scholar 

  69. Bocca E, Pignataro O. A conservative technique in radical neck dissection. Ann Otol Rhinol Laryngol. 1967;76:975–88.

    CAS  PubMed  Google Scholar 

  70. Calaero CV, Teatini G. Functional neck dissection; anatomical grounds, surgical technique, clinical observations. Ann Otol Rhinol Laryngol. 1983;92:21–2.

    Google Scholar 

  71. Anderson PE, Shah JP. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg. 1994;168:499–503.

    Google Scholar 

  72. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg. 1985;150:414–21.

    CAS  PubMed  Google Scholar 

  73. O’Brien CJ, Lahr CJ, Soong SJ. Surgical treatment of early stage carcinoma of the oral tongue: would adjuvant treatment be beneficial? Head Neck Surg. 1986;8:401–8.

    PubMed  Google Scholar 

  74. Shah JP, Andersen PE. Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. 1995;33:3–8.

    CAS  PubMed  Google Scholar 

  75. Pantvaidya GH, Pal P, Vaidya AD, Pai PS, D’Cruz AK. Prospective study of 583 neck dissections in oral cancers: implications for clinical practice. Head Neck. 2014;36(10):1503–7.

    PubMed  Google Scholar 

  76. Pellitteri PK, Robbins KT, Neuman T. Expanded application of selective neck dissection with regard to nodal status. Head Neck. 1997;19(4):260–5.

    CAS  PubMed  Google Scholar 

  77. Kolli VR, Data RV, Omer JB, Hicks Jr WL, Loree TR. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg. 2000;126(3):413–6.

    CAS  PubMed  Google Scholar 

  78. Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK, Shah JP, Cohen JI. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002;128(10):1180–4.

    PubMed  Google Scholar 

  79. Ambrosch P, Kron M, Pradier O, Steiner W. The purpose of this study was to evaluate the efficacy of selective neck dissection (SND) in elective and therapeutic treatment of the neck. Otolaryngol Head Neck Surg. 2001;124(2):180–7.

    CAS  PubMed  Google Scholar 

  80. Patel RS, Clark JR, Gao K, O’Brien CJ. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008;30(9):1231–6.

    PubMed  Google Scholar 

  81. Givi B, Linkov G, Ganly I, Patel SG, Wong RJ, Singh B, Boyle JO, Shaha AR, Shah JP, Kraus DH. Selective neck dissection in node-positive squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2012;147(4):707–15.

    PubMed  PubMed Central  Google Scholar 

  82. Feng Z, Gao Y, Niu LX, Peng X, Guo CB. Selective versus comprehensive neck dissection in the treatment of patients with a pathologically node-positive neck with or without microscopic extracapsular spread in oral squamous cell carcinoma. J Oral Maxillofac Surg. 2014;43(10):1182–8.

    CAS  Google Scholar 

  83. Parikh DG, Chheda YP, Shah SV, Patel AM, Sharma MR. Significance of level v lymph node dissection in clinically node positive oral cavity squamous cell carcinoma and evaluation of potential risk factors for level v lymph node metastasis. Indian J Surg Oncol. 2013;4(3):275–9.

    PubMed  PubMed Central  Google Scholar 

  84. Gallo O, Santoro R, Fiorini FR, Meccariello G, Laganà RM, Paiar F, Maio V. Prognostic role of internal jugular vein preservation in neck dissection for head and neck cancer. J Surg Oncol. 2013;108(8):579–83.

    CAS  PubMed  Google Scholar 

  85. Govers T, Patel S, Takes R, Merkx M, Rovers M, Grutters J. Cost-effectiveness of selective neck dissection versus modified radical neck dissection for treating metastases in oral cavity cancer patients; a modelling study. Head Neck. 2014. doi:10.1002/hed.23833 [Epub ahead of print].

    Article  Google Scholar 

  86. Feng Z, Niu LX, Yuan Y, Peng X, Guo CB. Risk factors and treatment of contralateral neck recurrence for unilateral oral squamous cell carcinoma: a retrospective study of 1482 cases. Oral Oncol. 2014;50(11):1081–8.

    PubMed  Google Scholar 

  87. Ord RA. Radical neck dissection. Atlas Oral Maxillofac Surg Clin North Am. 1997;5(2):91–110.

    CAS  PubMed  Google Scholar 

  88. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2015;37(2):1762–8.

    Google Scholar 

  89. Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953.

    PubMed  Google Scholar 

  90. Mabanta S, Mendenhall W, Stringer S, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591.

    CAS  PubMed  Google Scholar 

  91. Gleich LL, Ryzenman J, Gluckman J, et al. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma. Is salvage possible? Arch Otolaryngol Head Neck Surg. 2004;130:35.

    PubMed  Google Scholar 

  92. Ord RA, Kolokythas A, Reynolds MA. Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg. 2006;64(9):1409–14.

    PubMed  Google Scholar 

  93. Amar A, Chedid HM, Rapoport A, Dedivitis RA, Cernea CR, Brandão LG, Curioni OA. Update of assessment of survival in head and neck cancer after regional recurrence. J Oncol. 2012;2012:154303. doi:10.1155/2012/154303. Epub 2012 Oct 10.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, University of Maryland and the Greenebaum Cancer Center, Baltimore, MD, 21201, USA

    Robert A. Ord MD, DDS, FRCS, FACS, MS, MBA

  2. Oncology/Microvascular Program, Department of Oral and Maxillofacial Surgery, University of Maryland and the Greenebaum Cancer Center, Baltimore, MD, 21201, USA

    J. Lubek MD, DDS, FACS

Authors
  1. Robert A. Ord MD, DDS, FRCS, FACS, MS, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Lubek MD, DDS, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert A. Ord MD, DDS, FRCS, FACS, MS, MBA .

Editor information

Editors and Affiliations

  1. Department of Head and Neck, Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, Buffalo, USA

    Moni Abraham Kuriakose

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ord, R.A., Lubek, J. (2017). Management of the Neck in Oral Cavity Cancer. In: Kuriakose, M. (eds) Contemporary Oral Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-14917-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14917-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14916-5

  • Online ISBN: 978-3-319-14917-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation